EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749681 - denosumab
| ChEBI ID | CHEBI:749681 |
| ChEBI Name | denosumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. renoprotective agent Any compound that is able to prevent damage to the kidneys. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. appetite enhancer A drug which increases appetite. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| denosumab (CHEBI:749681) has role antineoplastic agent (CHEBI:35610) |
| denosumab (CHEBI:749681) has role antirheumatic drug (CHEBI:35842) |
| denosumab (CHEBI:749681) has role appetite enhancer (CHEBI:50779) |
| denosumab (CHEBI:749681) has role bone density conservation agent (CHEBI:50646) |
| denosumab (CHEBI:749681) has role gout suppressant (CHEBI:35845) |
| denosumab (CHEBI:749681) has role hypoglycemic agent (CHEBI:35526) |
| denosumab (CHEBI:749681) has role renoprotective agent (CHEBI:231911) |
| denosumab (CHEBI:749681) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| AMG 162 | ChEMBL |
| AMG-162 | ChEMBL |
| AMG162 | ChEMBL |
| Ct-p41 | ChEMBL |
| CTP-41 | ChEMBL |
| CTP41 | ChEMBL |
| Brand Names | Source |
|---|---|
| Prolia | ChEMBL |
| Prolia, ranmark xgeva | ChEMBL |
| Prolia, xgeva | ChEMBL |
| Xgeva | ChEMBL |